oxonic acid has been researched along with Hilar Cholangiocarcinoma in 2 studies
Oxonic Acid: Antagonist of urate oxidase.
Excerpt | Relevance | Reference |
---|---|---|
"Although the combination of cisplatin and gemcitabine (GEM) is considered the standard first-line chemotherapy against unresectable hilar cholangiocarcinoma (HC), its efficacy is discouraging." | 9.22 | Combined gemcitabine and S-1 chemotherapy for treating unresectable hilar cholangiocarcinoma: a randomized open-label clinical trial. ( Guan, J; Li, H; Tong, DN; Zhang, ZY; Zhou, GW; Zhou, ZQ, 2016) |
"Although the combination of cisplatin and gemcitabine (GEM) is considered the standard first-line chemotherapy against unresectable hilar cholangiocarcinoma (HC), its efficacy is discouraging." | 5.22 | Combined gemcitabine and S-1 chemotherapy for treating unresectable hilar cholangiocarcinoma: a randomized open-label clinical trial. ( Guan, J; Li, H; Tong, DN; Zhang, ZY; Zhou, GW; Zhou, ZQ, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hosoda, K | 1 |
Fukushima, K | 1 |
Shimizu, A | 1 |
Motoyama, H | 1 |
Kubota, K | 1 |
Notake, T | 1 |
Sugenoya, S | 1 |
Hayashi, H | 1 |
Yasukawa, K | 1 |
Kobayashi, R | 1 |
Soejima, Y | 1 |
Li, H | 1 |
Zhang, ZY | 1 |
Zhou, ZQ | 1 |
Guan, J | 1 |
Tong, DN | 1 |
Zhou, GW | 1 |
1 trial available for oxonic acid and Hilar Cholangiocarcinoma
Article | Year |
---|---|
Combined gemcitabine and S-1 chemotherapy for treating unresectable hilar cholangiocarcinoma: a randomized open-label clinical trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; CA-19-9 Antigen; D | 2016 |
1 other study available for oxonic acid and Hilar Cholangiocarcinoma
Article | Year |
---|---|
Survival Outcomes of Gemcitabine Plus S-1 Adjuvant Chemotherapy after Surgical Resection for Advanced Biliary Tract Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap | 2021 |